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Abstract  
Mind-body therapies are commonly recommended to treat vasomotor symptoms, such as hot flushes 
and night sweats (HFNS). The purpose of this systematic review was to evaluate the available 
evidence to date for the efficacy of different mind-body therapies to alleviate HFNS in healthy 
menopausal women and breast cancer survivors. Randomised controlled trials (RCTs) were identified 
using seven electronic search engines, direct searches of specific journals, and backwards searches 
through reference lists of related publications. Outcome measures included HFNS frequency and/or 
severity or self-reported problem rating at post-treatment. The methodological quality of all studies 
was systematically assessed using predefined criteria. 26 RCTs met the inclusion criteria. 
Interventions included yoga (n=5), hypnosis (n=3), mindfulness (n=2), relaxation (n=7), paced 
breathing (n=4), reflexology (n=1) and cognitive behavioural therapy (CBT) (n=4). Findings were 
consistent for the effectiveness of CBT and relaxation therapies for alleviating troublesome vasomotor 
symptoms. For the remaining interventions, although some trials indicated beneficial effects (within 
groups) at post-treatment and/or follow up, between group findings were mixed and overall, 
methodological differences across studies failed to provide convincing supporting evidence. 
Collectively, findings suggest that interventions that include breathing and relaxation techniques, as 
well as CBT, can be beneficial for alleviating vasomotor symptoms. Additional large, 
methodologically rigorous trials are needed to establish the efficacy of interventions on vasomotor 
symptoms, examine long-term outcomes and understand how they work.  
 
 
 
Introduction  
Hot flushes and night sweats (HFNS) or vasomotor symptoms are experienced by 65-80% of healthy 
menopausal women in Western cultures [1-2]. Women often describe these symptoms as recurrent 
periods of flushing, sweating and an intense heat sensation on their face and upper chest. HFNS are 
associated with disturbances of the temperature-regulating mechanism in the hypothalamus, triggered 
by a natural decline in oestrogen levels during the menopause transition [3]. Symptoms typically 
begin one year prior to menstrual period cessation and 10–30% of post-menopausal women continue 
to experience symptoms throughout their lives [4]. Symptoms can disrupt sleep, work and other daily 
activities [5-6]. 
HFNS are especially problematic in breast cancer patients, affecting 65-85% of women [7]. 
Treatments such as chemotherapy or adjuvant endocrine treatments can compromise ovarian function, 
resulting in rapid reduction of oestrogen levels - the major cause of HFNS [7]. Breast cancer survivors 
might have more frequent and severe flushes than women who undergo normal menopause [8]. 
Moreover, HFNS can last for several years, which can reduce treatment adherence [9]. Hormone 
replacement therapy (HRT), an effective treatment for HFNS, is usually contraindicated, particularly 
in oestrogen receptors positive cancers, due to cancer reoccurrence risks [10]. Therefore, there is a 
need among well women and breast cancer survivors for safe and effective non-hormonal treatments 
that are free from side-effects to support management of HFNS. 
Mind–body interventions include methods that are designed to “enhance the mind’s capacity to affect 
bodily function and symptoms” [11]. Such interventions include relaxation, paced breathing, clinical 
hypnosis, yoga, mindfulness, reflexology and cognitive behavioural therapies (CBT). Although these 
interventions have shown promise for the management of menopausal complaints by reducing stress 
reactivity, enhancing mood, wellbeing and improving sleep [4], their effectiveness for vasomotor 
symptoms remains less clear. Recent meta-analyses have emphasised the need for large randomised 
clinical trials (RCTs) to generate a sufficient evidence base to guide future clinical treatment decisions 
around the use of mind-body therapies for troublesome vasomotor symptoms [5, 12]. In addition, three 
recent commentaries or position statements have been published; however recommendations vary 
including the use of CBT and clinical hypnosis [13] to hormone replacement therapy [14], selective 
serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs) [15]. 
None of these statements were based on systematic review of the available literature of mind-body 
interventions for vasomotor symptoms. A recent systematic review of non-hormonal treatments of 
vasomotor symptoms did not include mind-body therapies [16]. Although a systematic review was 
published previously on this topic [17], it was based on searches which are now seven years old and 
did not include the more recent RCTs that have utilised CBT based interventions. The inclusion of 
CBT based interventions is important as behavioural and cognitive components of CBT may provide 
women with helpful behavioural strategies and awareness of activities that might trigger HFNS. In 
addition, the skills developed as part of CBT based programmes can give women a greater sense of 
control over their HFNS leading to symptom reduction. A UK NICE guidance [14] report focused 
only on papers that used frequency of HFNS as an outcome which lead to the exclusion of some mind-
body trials; we include frequency, severity and problem-rating as HFNS outcomes in this review. 
The aim of this systematic review was to critically evaluate evidence from available RCTs regarding 
the efficacy of mind-body therapies to alleviate HFNS in healthy, menopausal women and breast 
cancer survivors. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines [18] were used. We also outline major limitations in the current literature and 
discuss directions for future research. 
 
 
Methods  
Inclusion criteria  
RCTs published in peer-reviewed journals examining the effects of mind-body interventions (yoga, 
relaxation, paced breathing, mindfulness, clinical hypnosis, reiki, pilates, reflexology, CBT) on HFNS 
for women who were either a) peri or post-menopausal or b) breast cancer survivors or in active 
treatment for breast cancer and c) were experiencing troublesome HFNS. Outcome measures included 
HFNS a) frequency and/or b) severity or problem rating at post-treatment. Only trials reported in 
English were included. 
 
Exclusion criteria  
We excluded trials in which pharmaceutical treatments were studied as the main treatment unless they 
constituted a comparison condition or trials which did not specifically target HFNS symptoms. Case 
series and case studies were also excluded as were trials published in dissertation or abstract form or 
that did not report quantitative outcome data.  
 
Search strategy  
The databases Pubmed, Medline, PsycInfo, Cochrane Database of Systematic Reviews, Cochrane 
Central Register of Controlled Trials, Web of Science and Embase were searched from January 1980 
and up to 31st December 2015. Key term searching was undertaken (Table 1). Retrieval was limited to 
RCTs, English language and human participants (see Figure 1). Organic backwards (reference list 
search) and forward (citation search) searches were undertaken to identify additional relevant papers.  
No meta-analysis was performed due to the heterogeneity of the studies, e.g. variation in the 
menopausal status of women or length of treatments. However, where possible, and to allow 
comparisons across studies, we calculated effect sizes (Cohen’s d) [19] in measures of HFNS 
(frequency, severity or problem rating) for each study, separately (Tables 2 and 3).  
 
Quality ratings 
Study quality was evaluated using a standard quality assessment tool [20] using 14 established criteria 
(e.g. related to study rationale, study design, sample sizes). Quality ratings were conducted 
independently by two authors and minor differences were settled before deciding on the final scores 
(maximum possible score of 1). Quality ratings for included studies are also shown in Tables 2 and 3. 
 
Risk of bias  
Risk of bias was evaluated using the Cochrane Collaboration’s tool for assessing risk of bias (adapted 
from Higgins and Altman [21]) which covers: selection bias (random sequence generation and 
allocation concealment), performance bias (blinding of participants and personnel), detection bias 
(blinding of outcome assessment), attrition bias (incomplete outcome data) and reporting bias 
(selective reporting).  
 
 
Results  
Yoga  
Yoga is an Eastern spiritual discipline which includes breath control, simple meditation, and the 
adoption of specific bodily postures and can often be practised for promotion of health and relaxation. 
Many different styles of yoga exist, which vary in intensity, physical effort and relaxation component 
[22].  
1487 studies were identified. 1478 papers were excluded for not meeting inclusion criteria. 9 full-text 
articles were assessed. Two studies were not available in English [23-24] and two studies used the 
same participant population [25-28]. Therefore, 4 RCTs for healthy women [26, 28-30] and 1 for 
breast cancer survivors [31] were included.  
There was heterogeneity amongst studies employing various forms of yoga interventions with some 
being essentially meditative [31], whereas others focusing on breathing [26, 30, 31] or addressing 
physical positions [28-30]. Interventions lasted for 2-4 months; only one RCT [31] reported a long-
term follow-up.  
Overall, findings appear to be inconsistent regarding their effectiveness in alleviating symptoms, with 
some RCTs showing no HFNS efficacy compared to either exercise or control conditions [26-27, 30] 
or beneficial efficacy for HF but not NS compared to control conditions [31]. One RCT showed 
significant reductions in HFNS when compared to control but not exercise groups [29]. Additionally, 
in breast cancer survivors [31] although the yoga group improved with regard to symptom reporting, 
the reduction score was only 31%, which is similar to the placebo response seen in other trials [32]. 
 Reflexology  
Reflexology includes massage of certain areas of the feet and hands that correspond to certain glands, 
organs, and other parts of the body; local finger pressure may influence the function of organs and 
promote homeostasis, relaxation, allowing a healing process [33].  
102 studies were identified. 97 papers were excluded. Five full text articles were assessed. Four 
studies were further excluded as not available in English [34-36] or not examining HFNS as an 
outcome measure [37]. One RCT [33] for healthy women was included and comparison of 9 weeks of 
standard foot reflexology and routine foot massage reported no significant between-group differences 
in HFNS. 
 
Relaxation  
As central noradrenergic activity can be increased in women experiencing HFNS, relaxation may 
reduce sympathetic activity, and consequently, HFNS reporting [38-39].   
83 studies were identified. 71 papers were excluded and 12 full-text articles were assessed. Two 
studies used the same breast cancer population [35-36] in more than one article. 7 RCTs for healthy 
women and 4 for breast cancer survivors were therefore included. 
 
Applied relaxation therapy 
Applied relaxation therapy includes a number of systemic approaches to relaxation including PMR 
(e.g. repeatedly tensing and then releasing muscle groups), release-only relaxation (releasing muscle 
groups directly), cue-controlled relaxation (linking release-only relaxation to breathing), differential 
relaxation (practising skills in a range of situations), rapid relaxation, application training and 
maintenance program [51].  7 RCTs were included. Interventions lasted for 6-12 weeks and follow-up 
periods ranged from 3 to 6 months. An early trial of PMR [44] for heat stress induced symptoms in a 
laboratory setting showed beneficial effects in HFNS frequency in the menopausal but not control 
group. Irvin et al [50] yielded significant reductions in HFNS intensity (but not frequency) in the 
relaxation group at post-treatment. Nedstrand et al [42], applied relaxation (compared with estradiol 
treatment (ET)) and HFNS frequency decreased significantly in both groups and remained significant 
at 6 months follow-up. Nevertheless, reductions were faster in the ET group than in the relaxation 
group. Zaborowska et al [43] reported a significant reduction in HFNS frequency in the relaxation 
group compared to the placebo (but not the other comparators: acupuncture or ET) group.  
In a pilot study[48] no between group differences in HFNS was observed between relaxation training 
using deep breathing and guided imagery when compared with a waitlist condition. Nedstrand et al 
[40] compared relaxation with acupuncture and again, although both groups improved in HFNS 
frequency, there were no significant between-group differences at post-treatment or follow-up. More 
recently, Fenlon et al [49] compared applied relaxation (deep breathing, muscle relaxation and guided 
imagery) with a waitlist control group. There was a significant reduction in both flush frequency and 
severity ratings at post-treatment compared to the control group; severity, but not frequency, 
improvements were sustained at follow-up.  
 
Paced respiration 
Paced respiration involves taking 6 to 8 slow deep breaths per minute while inhaling through the nose 
and exhaling through the mouth [47]. Four RCTs were included. Interventions lasted for 4-16 weeks 
and only one RCT reported a follow-up period [47].  
Freedman and Woodward [45] reported decreased HFNS frequency following paced-respiration 
compared with progressive muscle relaxation and electroencephalographic biofeedback (control 
groups) using physiological measurement of HFNS frequency. Subsequently Freedman and 
colleagues [46] compared paced respiration with EEG biofeedback again and showed similar results 
for paced respiration. Nevertheless, in Huang et al [52], a paced respiration intervention using a 
portable guided-breathing device was significantly less effective than a music-listening intervention in 
decreasing both frequency and severity of HFNS. 
Carpenter et al [47] compared paced respiration, an attention control condition of fast shallow 
breathing, or usual-care control but no significant changes were found between groups.  
 
Mindfulness / Mindfulness-Based Stress Reduction (MBSR) 
Mindfulness encourages individuals to discriminate more accurately between thoughts, feelings and 
physical sensations whilst developing a non-reactive awareness of these [53].  53 studies were 
identified. 46 papers were excluded for not meeting inclusion criteria. 5 papers were further excluded 
for not being an RCT [54-55] or did not use HFNS as an outcome measure [56-58]. Therefore, two 
RCTs were included in the final analysis. Carmody et al [59] reported beneficial effects of MBSR on 
HFNS bother (but not HFNS frequency) at 9 and 20 weeks post-treatment. Bower et al [61] compared 
a mindfulness intervention group or to a wait-list group. The intervention led to significant reductions 
in HFNS although effects were not maintained at 3-months follow-up.  
 
Hypnosis / Mental Imagery 
Hypnosis aims to create a deeply relaxed state using mental imagery where individuals are guided to 
respond to the therapist’s suggestions for changes in subjective experience, alterations in perception, 
sensation, emotion, thought, or behaviour[62]. It is argued that regular practice of clinical hypnosis 
improves parasympathetic tone, resulting in reduced HFNS symptoms [63]. 
78 studies were identified. 75 papers were excluded. Three full-text articles were assessed. Two RCTs 
examined the possible effects of hypnosis on HFNS in breast cancer survivors [64-65] and one RCT 
[63] in well women. Interventions lasted for 5-8 weeks and only one RCT reported a follow-up period 
[63].  
Elkins et al [64] showed that breast cancer survivors who received five weekly sessions of clinical 
hypnosis experienced fewer HFNS compared to a waitlist control group; also, a 69% reduction in hot 
flushes relative to baseline. In another trial [65], breast cancer survivors who received eight weekly 
sessions of hypnosis experienced a 80% reduction in hot flushes at post-treatment relative to baseline, 
although it should be noted that the sample size was small (N=15).  
One RCT [63] was identified in healthy women showing that hypnosis resulted in significant 
reductions in both self-reported and physiologically measured HFNS compared to a structured control 
condition; findings remained significant at 12 week follow-up.  
  
Cognitive Behavioural Therapy (CBT) 
The CBT approach aims to help individuals to moderate change overly negative cognitions (thoughts 
and beliefs) and unhelpful behaviours in order to help alleviate troublesome emotional and/or physical 
symptoms and improve their quality of life. 
26 studies were identified. 22 papers were excluded for not meeting the inclusion criteria. 
Consequently, four RCTs were included in the final analysis. Two RCTs were carried out in breast 
cancer survivors [71-72] and two in healthy women [73-74]. In Mann et al [71], group CBT 
significantly reduced HFNS problem rating at 9 weeks post-treatment compared with usual care and 
improvements were maintained at 26 weeks follow-up (MENOS 1). Duijts et al [72], women 
randomly assigned women to CBT, physical activity (PE), CBT and PE combined or control group. 
The groups that included CBT showed a significant decrease in HFNS problem rating at 12-week 
post-treatment and 6-month follow-up.  
Ayers et al [73] showed significant reductions in HFNS problem rating and NS frequency in Group 
and Self-Help CBT at post-treatment and follow-up compared to the usual care group (MENOS 2). 
Furthermore, Keefer et al [70], compared 8 weekly sessions of Group CBT to a waitlist control 
condition, and found that CBT significantly reduced HFNS frequency compared to the waitlist control 
at the end of treatment. Nevertheless, the sample size was quite small.   
 
Reiki/Pilates 
We did not find any RCTs examining the effects of reiki or pilates on HFNS.    
 
 
Discussion 
The aim of this systematic review was to examine available evidence to date regarding the efficacy of 
a range of mind-body therapies to alleviate HFNS in well women and breast cancer survivors. The 
majority of the interventions focused on hot flush frequency as the main outcome. Fewer studies 
focused on ratings of hot flush severity or problem ratings. Of those that did, reductions in hot flush 
problem or severity ratings were reported for interventions utilising applied relaxation training (breast 
cancer patients), paced respiration (healthy women), mindfulness (healthy women) and CBT (healthy 
women and breast cancer patients).  
CBT, including paced respiration was shown to be effective for HFNS for breast cancer survivors [70] 
and healthy, menopausal women [73]. Moreover, during interviews conducted at the end of these 
trials [71, 73] women reported positive experiences of the intervention and considered paced 
breathing as particularly helpful [83-84]. Findings from this review suggest that interventions that 
include breathing and relaxation techniques may help reduce HFNS reporting in well women, 
although evidence was less strong for paced breathing applied to breast cancer survivors [47]. 
Nevertheless, since RCTs often combined paced breathing or other relaxation exercises with other 
therapies, such as mental focusing [50] or CBT [71, 73], future studies need to delineate their efficacy 
as stand-alone treatments.  
Overall, we found no consistent beneficial efficacy of yoga for HFNS compared with control groups, 
although improvements in other troublesome physical symptoms have been reported (e.g. fatigue [75], 
nausea and vomiting [76]). Neutral or positive effects of yoga have also been reported on quality of 
life and well-being for both well women [77] and breast cancer survivors [78-79]. For instance, a 
recent Cochrane review reported no differences between yoga and exercise in vasomotor symptom 
relief [80], making it thus difficult to differentiate the effects of yoga from engaging in other physical 
activities. In fact, exercise has not been found to impact upon HFNS over and above control 
conditions in recent trials [81-82]. Although yoga may have other benefits, its efficacy for alleviating 
HFNS is, therefore, yet to be established [12].  
Finally, there were few RCTs examining the effects of reflexology, clinical hypnosis or mindfulness-
based interventions for troublesome HFNS; although some trials of self-hypnosis and mindfulness 
reported promising results for both breast cancer survivors and well women, there is still insufficient 
research to consider any as evidence-based treatments. 
  
Possible mechanisms behind the beneficial effects of mind-body interventions on HFNS 
While underlying mechanisms remain unclear, there are several ways in which mind-body 
interventions might alleviate troublesome vasomotor symptoms. Behavioural interventions, such as 
hypnosis, mindfulness and/or other relaxation therapies are reported to reduce sympathetic activity, 
decrease sympathoadrenal reactivity, and enhance parasympathetic output, which may, in turn, reduce 
HFNS reporting [4, 85]. Such interventions may also reduce symptoms by improving other indices of 
psychological and physical health. For instance, interventions involving physical activity, such as 
yoga, have been reported to reduce body fat and improve lipid profiles [86], as well as alleviate stress 
and low mood difficulties [87], which have, in turn, been associated with HFNS problem rating and 
severity [88]. Moreover, changes in other lifestyle factors (e.g. diet, smoking) might also be 
associated with the beneficial effects of behavioural interventions on symptom reporting [89]. 
Mindfulness-based interventions might enable individuals to be less reactive to stressors and foster 
adaptation to troublesome symptoms in an effective way [90-91]. Although more large RCTs are 
needed to establish their efficacy on HFNS, such interventions might be promising for managing 
stressors that can accompany the menopausal transition. 
In regards to possible mechanisms of action of CBT in reducing vasomotor symptoms, the cognitive 
component of CBT encourages women to identify and challenge negative thoughts and/or beliefs 
about themselves and their symptoms [92]. The behavioural component of CBT involves increasing 
women’s participation in pleasurable activities, such as relaxation and exercise. CBT may thus 
provide helpful behavioural strategies and awareness of activities that might trigger HFNS [94]. Such 
skills can provide a greater sense of control over HFNS, which has been associated with symptom 
reduction [71, 73, 94-95]. By reducing emotional distress associated with the occurrence of flushes, 
CBT may also ameliorate reactions to HFNS that would otherwise exacerbate them [93]. Hunter and 
Chilcot reported that negative beliefs about HFNS were the strongest predictors of problem rating 
[97] and treatment effects on HFNS problem rating scores have been shown to be mediated by 
changes in beliefs about coping/control of HFNS and sleep [98]. CBT might work mainly at the level 
of symptom perception and cognitive appraisal where attention training away from bodily experiences 
and balancing overly negative appraisals might help to improve women’s experiences of HFNS [99].  
 
Methodological quality of studies 
Not all participants completed the interventions in the examined studies and data were not always 
analysed on an intention-to-treat basis. This may have introduced bias, overestimating the benefits of 
examined interventions. Only some of the studies reported treatment adherence rates, of which some 
studies indicated that adherence was positively associated with better outcomes. Whether adherence to 
the treatment sessions was affected by cancer-related symptoms or side-effects of cancer treatment 
was not reported; similarly, not all studies reported adverse effects and reasons for dropouts. Finally, 
since the control groups usually consisted of usual care, researchers and participants were not blinded 
to the interventions, possibly introducing bias. Future studies should ensure rigorous methodology and 
reporting, mainly adequate randomization, allocation concealment, intention-to-treat analysis, and 
blinding of at least outcome assessors. Future studies would also benefit from examining outcomes in 
terms of both the frequency of symptoms and the severity of self-reported problems associated with 
the symptoms. In addition, clear descriptions of the interventions should be provided together with a 
description of expertise of the instructors. Finally, although there was heterogeneity of the included 
interventions it is likely that different interventions share common techniques or common 
mechanisms. Therefore, to support understanding of why interventions may, or may not, work it is 
necessary to examine the efficacy not only of the global intervention but also of the components 
within interventions that may influence intervention efficacy. This would help support the optimal 
design of future interventions. 
 
Limitations  
We excluded other cancer populations where HFNS can be particularly problematic [100]. We also 
excluded exercise as a mind-body intervention but reviews were recently conducted in this area [80, 
82]. Few RCTs included long-term follow-ups, thus findings remain unclear in terms of the longer 
effects of the examined interventions for vasomotor symptoms. Findings from healthy women may 
not generalize to women with breast cancer or other populations because of differences in the 
underlying aetiology of HFNS [99, 102]. In addition, although HFNS in the groups appear to be 
physiologically similar [103], the higher frequency and severity of symptoms experienced in breast 
cancer survivors may require more intensive therapies [104]. Additional testing in more diverse 
groups is thus warranted. Placebo effects have been observed in trials evaluating complementary 
therapies for vasomotor symptoms [105]. However, some studies indicated sustained benefits post-
intervention, when the placebo effects would be expected to diminish. Finally, not all trials included 
comparison conditions that controlled for non-specific effects of treatment; such effects cannot 
therefore be ruled out.  
 
Conclusion 
This systematic review found little to moderate evidence for long term effectiveness of clinical 
hypnosis, yoga, mindfulness and reflexology interventions for vasomotor symptom relief in healthy 
menopausal women and breast cancer patients. Consequently, there is still insufficient research to 
consider any as evidence-based treatments. Findings were more consistent for the effectiveness of 
CBT and relaxation therapies. In line with the recommendations of the North American Menopause 
Society [13] this review supports the use of CBT as a relatively risk free non-pharmaceutical therapy 
for the management of vasomotor symptoms. Although NAMS recommend the use of clinical 
hypnosis, this analysis suggests that further trials are required.  Mind-body interventions may offer a 
safe and inexpensive alternative to HRT treatments, particularly for women seeking non-hormonal 
therapies either instead of HRT or in addition to it. More rigorous research is needed to compare the 
effectiveness of mind-body interventions and to understand how these interventions work.  
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Current knowledge on the subject 
• Mind–body interventions have shown promise for the management of menopausal complaints 
including enhanced mood, wellbeing and improved sleep  
• Recent position statements regarding the management of menopausal symptoms make different 
recommendations regarding the role of mind-body interventions 
 
What this study adds  
• We critically evaluate evidence from available randomised controlled trials regarding the efficacy 
of mind-body therapies to alleviate vasomotor symptoms  in healthy, menopausal women and in 
breast cancer survivors 
• We found little to moderate evidence for long term effectiveness of clinical hypnosis, yoga, 
mindfulness and reflexology interventions for vasomotor symptom relief in healthy menopausal 
women and breast cancer patients.  
• In line with the recommendations of the North American Menopause Society this review supports 
the use of CBT as a relatively risk free non-pharmaceutical therapy for the management of 
vasomotor symptoms 
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Figure 1: Flow chart of identification and selection of studies 
Search electronic databases Medline, 
PsycInfo and EMBASE using key 
search terms  
1829 studies obtained 
Review titles and abstracts of search 
results 
Obtained 40 full text relevant articles  
1789 excluded as did not meet 
inclusion criteria  
 
Review full text of identified articles 
and apply inclusion/exclusion criteria 
Excluded 14 studies: 
 
- Did not use HFNS as an outcome 
measure 
- Not an RCT 
- Multiple studies reporting the 
same sample 
- Not in English 
26 studies included in the review 
10 studies with breast cancer patients 
16 studies with healthy participants 
Table 1: search terms 
 
 
mind-body terminology 
relaxation OR applied relaxation OR progressive muscle OR PMR OR yog$ OR breathing OR paced 
breathing OR paced-breathing OR mind body OR mind-body OR pilates OR reiki OR reflexology OR 
meditation OR mindfulness OR hypnosis OR imagery OR complementary therap$ OR alternative 
therap$ OR cognitive behavioural therapy OR CBT]  
 
AND menopaus$ OR peri-menopaus$ OR post-menopaus$ OR climacter$ OR well women OR well-
women OR vasomotor OR hot flash$ OR hot-flash$ OR hot flush$ OR hot-flush$ OR night sweat$ OR 
night-sweat$].  
 
The above procedure was repeated for breast cancer women alone with “breast cancer OR cancer OR 
cancer survivors” replacing menopaus$ OR peri-menopaus$ OR post-menopaus$ OR climacter$ OR 
climacter$ OR well women OR well-women”. 
 
Table 2. RCTs recruiting healthy menopausal participants 
 
Author (s), 
year 
Country Study Population  
 
Intervention Comparison 
Condition(s) 
Measures Findings  Cohen’s d Quality 
ratings 
YOGA    
Elavsky & 
McAuley, 
2007 1 
 
 
 
USA 
 
164 pre, peri, and 
post-menopausal 
women  
 
42–58 yrs  
 
Race: White (83%) 
 
(no HRT)  
4 months 
 
Iyengar Hatha  
(breathing and 
posture practices, 
meditation):  
 
90 min*2/wk classes 
and home practice  
4 months 
 
(1) Walking:  
1 hr*3/wk classes 
and home- 
individualized 
exercise 1-2 
days/wk 
 
(2) Waitlist 
control 
GCS  
(HFNS bother) 
 
 
Yoga vs. control: ns  
 
Yoga vs. walking: ns  
 
Adherence (ns):  
Walking (70%) > yoga 
(63%)  
d=0.2 
 
d=0.1 
 
0.7 
Chattha et 
al,  
20082  
 
 
 
India 
 
120 peri-menopausal 
women  
 
40–55 yrs 
 
(no HRT)  
 
2 months 
IAYT  
(breathing and 
posture practices, 
meditation) 
Classes: 1Hr*5 /wk 
2 months 
 
(1) Stretching 
exercise 
classes  
 
 
1Hr*5 /wk 
VCL  
(HFNS severity) 
 
 
 
HFNS severity: ns 
 
Adherence: 90% 
HF: d=0.2 
NS: d=0.3 
0.8 
Afonso et 
al, 2012 3 
 
 
Brazil 61 post-menopausal 
women 
 
50–65 yrs 
 
(no HRT) 
 
4 months 
Yoga (asana, 
bhastrika, relaxation)  
classes: 
 
60 min*2/wk  
 
4 months 
 (1) Passive 
stretching  
60 min*2/wk  
 
(2) Waitlist control  
KMI 
(HFNS severity) 
 
Yoga vs. stretching: ns  
 
Yoga<waitlist 
 
 
Adherence: 74%  
d=0.2 
 
d=0.9 
 
 
0.6 
Newton et 
al, 2014 
USA 249 peri- or post-
menopausal women 
or with hysterectomy  
3 months   
Yoga (breathing 
exercises, physical 
3 months  
(1) exercise  
(2) usual 
activity  
Diary  
(HFNS 
frequency, 
Yoga vs. exercise: ns  
 
Yoga vs. usual activity: 
ns  
Unable to 
calculate 
0.8 
40-62 yrs postures and 
meditative practice) 
classes:  
90 min * 1/wk and 
home practice 
bother)  
Adherence: 95% 
MINDFULNESS    
Carmody 
2011 14 
 
 
USA 110 peri or 
postmenopausal 
women ≥5 
HFNS/day 
(moderate to severe)  
 
47–69 yrs  
 
(incl. cancer 
survivors ≥ 6 months 
from treatment 
completion) 
9- weeks and 3 
month follow-up 
 
8 MBSR (2.5h) 
classes (n=25) plus 
one day class on the 
6th week.  
(body scan, sitting 
meditation attending 
to thoughts and 
emotions, bodily 
sensations and 
breathing; stretching 
exercises) 
 
Two CDs for home 
practice (45 min* 6 
days/week) 
 
 
 
Waitlist control 
Diary 
[HFNS bother, 
intensity 
(frequency x 
severity)] 
 
 
HFNS bother: 
MBSR < C  
 
HFNS intensity: ns 
 
Adherence: 81% 
Unable to 
calculate  
0.8 
RELAXATION  
Germaine, 
198415 
 
USA 
 
14 postmenopausal 
women  ≥2 
HFNS/day 
 
44–61 yrs 
 
12 premenopausal 
women/controls 
 
6 weeks and 6 month 
follow-up 
(Heat stress 
induction)  
 
PMR training: 
(16, 7 and 2 muscle 
groups for 2 sessions 
each)  
6 weeks and 6 
month follow-up 
(Heat stress 
induction)  
 
α-EEG biofeedback 
(control):   
1 hr*1/wk 
and home practice: 
Diary  
(HF frequency)  
 
 
PMR < C at post-t and 
FU  
 
 
Unable to 
calculate  
0.5 
22-45 yrs 1 hr*1/wk 
and home practice: 
2x/day 
2x/day 
Irvin, 
199616 
 
USA 33 postmenopausal 
women ≥5 
HFNS/day 
 
44–66 yrs 
10 weeks 
 
RR training:  
(mental focusing 
using diaphragmatic 
breathing and breath 
awareness) 
3 (60 min) sessions* 
10 wks, then audio 
tape for home 
practice 
≥20 min*1/day 
10 weeks 
 
Reading (Placebo) 
Training: 
3 (60 min) 
sessions* 10 wks, 
then audio tape for 
home practice 
≥20 min*1/day 
 
 
Charting (control) 
Diary  
(HFNS 
frequency, 
intensity) 
 
 
Frequency: ns 
 
Intensity:  
RR< C groups  
 
Adherence: 74% 
Unable to 
calculate 
0.7 
Nedstrand, 
200517 
 
Sweden 
 
30 postmenopausal  
women with 
moderate to severe 
symptoms 
 
 
48–63 yrs  
 
 
12 weeks and 6 
month follow up  
 
AR groups (n=4-6):  
 
60 min*1/wk plus 
home practice ≥ 
1/day 
 
12 weeks and 6 
month follow up  
 
ET  
 
(17β estradiol) 
2 mg* day  
 
Diary  
(HFNS 
frequency) 
 
HFNS frequency 
decreased in both 
groups but faster in ET 
 
ET < AR 
at post-t and FU 
 
Adherence: 94% 
Unable to 
calculate 
0.8 
Zaborowska 
et al, 200718 
 
 
Sweden  102 postmenopausal 
women 
12 weeks 
 
AR groups (n=4-6)  
 60 min* 1/wk plus 
home practice  
≥1/day 
12 weeks 
 
AT  
(fixed points, 5-20 
mm) plus electrical 
stimulation  
(4 fixed points, 2 
Hz)   
30 min* 2/wk for 
the first 2 weeks 
and then 30 min* 
Logbook 
(HFNS 
frequency) 
ET < AR, placebo  
 
AR vs. AT: ns 
 
AR, AT < placebo 
 
 
Unable to 
compute 
0.8 
1/wk for another 10 
weeks 
 
ET 
(17b-estradiol) 
2 mg/day*12 wk 
 
Placebo tablets  
PACED RESPIRATION (PR) 
Freedman, 
199219 
USA 
 
33 postmenopausal  
women≥5 HFNS/day 
 
White (64%) 
4 weeks 
 
Paced Respiration 
training:  
1 hr*2/wk 
 
 
4 weeks 
 
Muscle relaxation 
(MR) training:  
1 hr*2/wk  
 
α-wave 
biofeedback 
(Placebo Control) 
Training:  
1 hr*2/wk 
 
SSC monitoring 
(HFNS 
frequency)  
 
 
 
PR< MR, C 
 
 
Unable to 
calculate 
0.5 
Freedman et 
al, 199520 
 
USA 24 postmenopausal  
women≥5 HFNS/day 
 
White (66.67%)  
16 weeks 
 
8 PR training 
sessions:  
1 hr*biweekly 
 
16 weeks 
 
α-wave 
biofeedback 
(Placebo Control) 
Training:  
1 hr*2/wk 
SSC monitoring 
(HFNS 
frequency)  
 
PR< C 
 
Unable to 
calculate  
0.5 
Huang et al, 
2015 
USA 123 peri- or post-
menopausal 
women≥4 
HFNS/day*w/k 
 
White (60%)  
 
12 weeks  
 
15 min in-person 
instruction and home 
practice 15 min*day  
12 weeks 
 
Music-listening 
device without 
guiding breathing 
Diary  
 
(HFNS 
frequency, 
severity) 
 
 
PR>C 
 0.9 
REFLEXOLOGY 
Williamson 
et al, 200221 
UK 80 symptomatic  
women ≥ 3 months 
 
45-60 yrs 
 
(no HRT) 
 
19 weeks and 1 
month follow-up  
 
9 sessions using 
precision reflexology 
(45 min) 
 
19 weeks and 1 
month follow-up  
 
9 sessions of foot 
massage without 
any reflexology 
strokes (45 min) 
HFNS 
frequency 
 
HFNS severity  
 
Frequency, severity: ns  
 
Adherence: 96% 
HFNS 
frequency: 
Unable to 
compute 
 
HF severity: 
d= 0.1 
NS severity: 
d=0.2 
0.6 
HYPNOSIS   
Elkins et al, 
201322 
 
USA 187 postmenopausal 
women ≥7 
HFNS/day or  
≥50 HFNS/wk 
6 weeks and 3 
months follow-up 
 
Individualized 
sessions (45 min)  
(mental imagery for 
coolness, safe place 
imagery, relaxation)  
plus self-hypnosis 
CD used for daily 
home practice  
 
Structured attention 
control condition 
HFSD 
[HFNS 
frequency, score  
(severity x 
frequency)] 
 
SSC monitoring 
(HFNS 
frequency)  
 
 
HFNS  frequency: 
H< C  
 
HFNS score:  
H< C 
 
at post-t and FU 
 
Adherence: 94% 
HFSD 
frequency:  
d= 1.27 
score:  
d= 1.21 
 
 
 
0.8 
CBT 
Keefer and 
Blanchard, 
200523 
USA  19 peri or 
postmenopausal  
women  
8 weeks 
 
Group CBT  
90 min sessions  
(psychoeducation, 
paced respiration, 
cognitive 
restructuring) plus 
paced respiration 
home practice  
Waitlist  Diary 
(HFNS 
frequency, 
problem rating) 
 
 
Frequency: 
CBT < WL 
Frequency: 
d=0.8 
 
Problem 
rating: 
d=0.4 
 
0.7 
Ayers et al, UK 140 women ≥ 10 6 weeks and 26  HFRS Problem rating, NS  0.9 
201224 problematic 
HFNS/week for  ≥1 
month 
weeks follow-up 
 
Group CBT  
 
Self-Help CBT  
 
 
 
 
Usual care 
(HFNS 
frequency, 
problem rating) 
 
SSC monitoring 
(HFNS 
frequency)  
 
 
frequency:  
CBT < UC  
at post-t and FU  
Key: IAYT=Integrated Approach to Yoga Therapy; GCS=Greene’s Climacteric Scale; KMI = Kupperman Menopausal Index; AT= Acupuncture Therapy; 
SNI=Superficial needle insertion; ET= estrogen therapy; SA= Sham Acupuncture; WSCL=Wiklund Symptom Check List; Pittsburgh Sleep Quality Index; 
HFRDIS =Hot Flash Related Daily Interference Scale; MENQOL=Menopause-Speciﬁc Quality of Life; ISI=Insomnia Severity Index; Menopausal Symptom 
Questionnaire; MBSR=mindfulness-based stress reduction; SCL-90-R=Hopkins Symptom Checklist; PSS=Perceived Stress Scale; WHIIRS=Women’s Health 
Initiative Insomnia Rating Scale; KI=Kupperman Index; EPI=Eysenck’s Personality Inventory; PSQI =Pittsburgh Sleep Quality Index; UQOL =Utian Quality of 
Life Scale; SWLS= Satisfaction with Life Scale; PMR=Progressive Muscle Relaxation; MIS= Menopausal Index Scale; POMS =Profile $Mood Scale; 
MRS=menopausal rating scale 
 
 
 
Table 3. RCTs recruiting women with a diagnosis of breast cancer  
Author(s), year 
 
Country Study Population  
 
Intervention Comparison 
Condition 
Measures Findings  Effect 
sizes  
Quality 
ratings 
YOGA    
Carson et al., 
2009 1 
 
USA 
 
37 early cancer 
survivors  
with ≥ 1 HFNS/day* 
≥4 days/wk 
  
54.4±7.5yrs 
 
Race: White (81.1%) 
 
(no HRT) 
2 months and 3 
month follow-up 
 
Yoga  Awareness 
Classes[gentle 
postures, 
meditation, 
and breathing 
exercises]: 
 
120min*1/wk 
and daily home CD 
practice  
2 months and 3 
month follow-up 
 
Waitlist control 
 
 
 
HF frequency, 
severity 
 
HF total  
(frequency x 
severity) 
 
NS frequency  
 
 
 
HF frequency, 
severity, total:  
Yoga < Waitlist 
at post-t and FU 
 
 
 
Adherence: 81%  
Unable to 
calculate 
0.7 
MINDFULESS 
Bower et al, 
2015 
 
 
 
 
USA 61 women with early 
stage breast cancer at 
or before age 50 
 
6 weeks and 3 
month follow up 
 
Mindful Awareness 
Practices (MAPS) 
intervention group   
 
6 weeks and 3 
month follow up 
 
Wait-list 
control group  
HFNS frequency MAPS < 
Waitlist at post-t 
only 
Unable to 
calculate 
0.9 
HYPNOSIS   
Elkins et al, 
20087 
USA 60 cancer survivors  
≥ 14 HFNS/wk for ≥ 1 
month 
5 weeks 
50 min sessions  
(mental imagery; 
suggestions for 
relaxation and 
coolness;  
dissociation from 
HFNS; positive 
Waitlist  HFNS total score  
(severity x 
frequency) 
 
 
HFNS total 
score:  
H < C 
 
 
 
Unable to 
calculate 
0.6 
suggestions; 
imagery for the 
future)  
plus home practice 
(CD) 
  
David et al, 
20138 
 15 women with breast 
cancer or an increased 
risk of breast cancer  
≥ 1HFNS/day 
 
42-63 yrs  
 
8 weeks  
60 min sessions 
plus home practice 
(CD) 
 
Gabapentin 900 
mg/day in three  
doses (control) 
Diary  
(HFNS severity, 
frequency) 
 
 
ns 
 
 
Unable to 
calculate 
0.6 
RELAXATION    
Fenlon, 19999 
 
UK 
 
24 (non-metastatic) 
patients with 
troublesome HFNS 
 
29–74 yrs 
 
 
White (100%) 
Relaxation 
(deep breathing 
with guided 
imagery): 
 
2 weekly sessions  
and home practice 
Waitlist  VAS  
(HFNS 
frequency, 
problem rating)  
 
 
 
ns 
 
 
Adherence: 71% 
Unable to 
calculate  
0.7 
Nedstrand et al, 
200610 
 
 
Sweden 
 
38 postmenopausal 
women ≥ 2HFNS/day 
 
30–64 yrs 
 
(no HRT ≤ 3 months) 
12 weeks and 6 
month follow up 
 
AR groups (n=5-6)  
60 min*1/wk 
and home practice:  
≥ 15-20/day 
 
12 weeks and 6 
month follow up 
 
AT  
(8 fixed points, 
5-20 mm) plus 
electrical 
stimulation  
(4 fixed points, 
2 Hz)   
30 min*2/wk for 
2 wks, then 30 
Diary 
(HFNS 
frequency) 
 
ns 
 
Adherence: 82% 
d= 0.1 0.7 
min*1/wk for 10 
wks 
Fenlon, 200811 
 
 
UK 
 
150 postmenopausal  
women   
 
36–77 yrs 
 
White (93%)  
 
(no HRT) 
4 weeks and 3 
month follow-up 
 
Relaxation  
(deep breathing 
with guided 
imagery and 
muscle relaxation):  
 
One 60-min, 1:1 
session, then audio 
tape 20 min*day 
for 4 weeks  
(home practice) 
 
 
 
 
60 min with a 
specialist nurse 
discussing 
HFNS  
(control) 
Diary 
(HFNS 
frequency, 
severity) 
 
 
 
Frequency: 
R<C at post-t  
 
Severity:  
R<C at post-t 
and FU 
 
 
 
Adherence: 60% 
Unable to 
calculate  
0.8 
PACED RESPIRATION 
Carpenter et al, 
201212 
 
 
USA 218 women  
(96 cancer survivors; 
122 healthy women) 
 
cancer survivors (non-
metastatic) > 4 weeks 
after treatment 
completion  
 
8 weeks and 16 
weeks follow up 
 
CD and paper 
booklet with 
instructions on PR  
Practice 2*day for 
15 min and apply at 
the onset of HFNS 
Shallow 
breathing (SB):  
Digital 
videodisc with 
paper booklet  
Practice 2*day 
for 15 min and 
apply at the 
onset of HFNS 
 
 
Usual care (UC) 
group 
Diary  
(HFNS 
frequency, 
severity, bother) 
 
 
ns  
 
Adherence: 92% 
PR vs. UC 
Frequency 
d=0.2  
Severity: 
d=0.3  
Bother: 
d=0.4  
 
PR vs.SB 
Frequency 
d=0.1  
Severity: 
d=0.2  
Bother: 
d=0.1 
0.9 
   
CBT  
Mann et al, 
201213 
 
UK 96 women after the 
end of cancer 
treatment with ≥ 
problematic 
10HFs/wk for  
≥ 2 months  
 
 
6 weeks and 26 
week follow-up 
 
Group CBT 
 
 
 
Usual care 
HFRS 
(HFNS 
frequency, 
problem rating) 
 
SSC monitoring 
(HFNS 
frequency) 
Problem rating: 
CBT < TAU at 
post-t and FU  
  
HFRS 
problem 
rating: 
d=0.6 
 
frequency: 
d=0.2 
0.9 
Duijts et al, 
201214 
 
 
Netherlands  422 early stage cancer 
survivors  
6 weeks and 6 
month follow-up 
 
Group CBT 
 
 
 
PE  
 
CBT/PE 
 
Usual care 
 
HFRS  
(frequency, 
problem rating) 
 
Problem rating: 
CBT, 
CBT/PE<TAU 
at post-t and FU  
 
Frequency: ns 
Problem 
rating: 
CBT vs. 
TAU: d=  
0.4,  
 
CBT/PE 
vs. TAU: 
d= 0.5 
0.9 
Key: PSQI = WSCL=Wiklund Symptom Check List; Pittsburgh Sleep Quality Index; HFRDIS =Hot Flash Related Daily Interference Scale; 
MENQOL=Menopause-Speciﬁc Quality of Life; ISI=Insomnia Severity Index; Menopausal Symptom Questionnaire; MBSR=mindfulness-based stress reduction; 
SCL-90-R=Hopkins Symptom Checklist; PSS=Perceived Stress Scale; WHIIRS=Women’s Health Initiative Insomnia Rating Scale; KI=Kupperman Index; 
GCS=Greene’s Climacteric Scale; GHQ=General Health Questionnaire; STAI= Spielberger State/Trait Anxiety Index; MenQOL=Menopause Specific Quality of 
Life Questionnaire; SF-12= Short Form 12-Item Survey; BDI=Beck Depression Inventory-Primary Care;  NCICTC=National Cancer Institute Common Toxicity 
Criteria 
 
 
